CARE™ Perspectives Report from DDW 2020 CARE™ Gastroenterology Faculty have reviewed the latest news and updates informed by the abstracts from DDW 2020. While Faculty consider news and developments across...

CARE™ Perspectives Report from EULAR 2020 provides a summary of the most compelling stories and news presented. While CARE™ Rheumatology Faculty consider news and developments across all areas, this particular...

The introduction of targeted therapy has revolutionized the treatment of many hematological disorders. Significant improvements in survival seen in clinical trials have resulted in approvals and funding based on Phase…

The American Association for Cancer Research (AACR) recently hosted the first portion of their 2-part annual virtual meeting on April 27th – 28th This CARE™ Update from AACR focuses on…

Members of the CARE™ Hematology Faculty recently met at the CARE™ Winter Hematology Update (WHU) 2020 (February 2020, Toronto ON). As an extension of this meeting, CLL and MM specific...

About Issue 2 The CLL treatment landscape is evolving in Canada. Recent data, funding/drug approval updates, and integration of novel agents have made clinical decisions more complex. To provide context...

The CLL treatment landscape is evolving in Canada. Recent data, funding/drug approval updates, and integration of novel agents have made clinical decisions more complex. To provide context and guidance on...

Recent advancements in the CLL treatment landscape have prompted members of the CARE™ Faculty to discuss how these developments could affect the practice of KOLs across the globe. CARE™ Faculty...

Recent advancements in the CLL treatment landscape have prompted members of the CARE™ Faculty to discuss how these developments have affected the practice of KOLs across the globe. CARE™ Faculty...

The Annual ASCO Genitourinary Cancers Symposium (GUCS) meeting took place on February 13 – 15 in San Francisco, California. In this issue of CARE™ Perspectives ASCO GUCS: Succinct recap of…